US Patent Issued to CureVac on June 9 for "Method of RNA in vitro transcription using a buffer containing a dicarboxylic acid or tricarboxylic acid or a salt thereof" (German Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,914, issued on June 9, was assigned to CureVac SE (Tubingen, Germany).

"Method of RNA in vitro transcription using a buffer containing a dicarboxylic acid or tricarboxylic acid or a salt thereof" was invented by Benyamin Yazdan Panah (Tubingen, Germany), Aniela Wochner (Tubingen, Germany), Tilmann Roos (Kusterdingen, Germany), Andreas Funkner (Tubingen, Germany) and Martin Kunze (Rottenburg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a buffer system comprising a dicarboxylic acid or tricarboxylic acid or a salt thereof for synthesizing RNA molecules as well as a method of RNA in vitro transcription using t...